Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care

Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: PR Newswire
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma170% of people with diabetes said supportive comments from others can significantly boost their motivation to manage their condition1Abbott launches film that highlights challenges of living life with diabetesABBOTT PARK, Ill., Feb. 4, 2025 /PRNewswire/ -- 'One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how everyday comments like these may affect people living with diabetes.Experience the full interactive Multichannel News Release here: https://www.multivu.com/abbott/9294252-en-abbott-above-the-bias-film-aims-to-reduce-stigma-about-diabetesPeople living with diabetes – which now includes 1 in 6 adults in America2 – face many barriers to receiving care. Survey data reveal that the misconceptions and stereotypes around the
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- ABT Stock to Gain From FDA IDE Approval for Its Coronary IVL System [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (NYSE:ABT) Receives FDA Approval For Coronary IVL System Trial In US [Yahoo! Finance]Yahoo! Finance
- Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery Disease [Yahoo! Finance]Yahoo! Finance
- Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery DiseasePR Newswire
ABT
Earnings
- 1/22/25 - In-Line
ABT
Sec Filings
- 3/14/25 - Form ARS
- 3/14/25 - Form DEFA14A
- 3/14/25 - Form DEF
- ABT's page on the SEC website